TOP STORIES

• REGULATORY Chugai’s Antibody Cocktail Up for PAFSC Review on July 19, 4th COVID-19 Drug If Approved
  July 13, 2021

• COMMENTARY Attention Grows for INES Drug Pricing Proposal; Will It Become Next Card on Reform?
  July 12, 2021

• ACADEMIA Japan Needs Discussions on Target Population of Aducanumab: Clinician
  July 12, 2021

• BUSINESS Fueled by Roivant Deal, Sumitomo Dainippon Accelerating DX as It Looks Beyond Latuda LOE
  July 9, 2021

• BUSINESS FDA Updates Aduhelm Label to Only Cover MCI, Mild Alzheimer’s
  July 9, 2021

• BUSINESS Edirol, Generic Drugs All Now Face Supply Curbs as Nichi-Iko Woes Spill Over
  July 8, 2021

• BUSINESS Bristol Myers Kicks Off COVID-19 Inoculation Program, Eliminates Cost Burden on Employees
  July 8, 2021

• BUSINESS 26 Japan Drug Makers’ Annual Pay Averages 8.21 Million Yen, 5 Firms Top 10 Million Yen Mark
  July 7, 2021

• BUSINESS Astellas Revamping Sales Organization as Product Mix Shifts towards Specialty Area: CEO
  July 6, 2021

• BUSINESS Sagent Jettisons Camostat Mesilate for COVID-19 after PII Miss: Nichi-Iko
  July 6, 2021

• BUSINESS All Ranitidine Tablet Drugs to Be Discontinued in Japan over Carcinogen Woes
  July 5, 2021

• BUSINESS Ivermectin to Enter 1st Company-Sponsored COVID-19 Trial in Japan
  July 2, 2021

• BUSINESS 3 Major Wholesalers, 7 Employees Found Guilty in Bid-Rigging Trial
  July 2, 2021

• BUSINESS Ayumi to Leverage IT to Boost Sales and Marketing, Eyes More Licensing Deals
  July 2, 2021

• BUSINESS New BMS Japan Boots Up with Richer Cancer Assets as Celgene Merger Closes
  July 1, 2021

• BUSINESS 2 Ono Employees Found Guilty for Onoact Bribery Charges; Scholarship Donation in Spotlight
  June 30, 2021

• BUSINESS Chugai Files Regeneron’s Antibody Cocktail in Japan
  June 30, 2021

• BUSINESS Organon Japan to Focus on Women’s Health, Enrich Offerings with Global Products: President
  June 29, 2021

• BUSINESS MSD Chief Wants Japan to Eliminate Disincentives Tied to Re-Pricing Rules as Keytruda Faces Repeated Cuts
  June 28, 2021

• ACADEMIA Architect of Oncolytic Virus Therapy Looks to Its Use in All Solid Cancers in 5 Years
  June 25, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 85
• 86
• 87
• 88
• 89
• 90
• 91
• 92
• 93
• …
• Next ›
• 最終 »